Skip to content

Clinical trials

Bone Diseases trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bone Diseases Country / region: Australia Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20125
20142
20151
20162
20171
20181
20192
20202
20212
20231
20243
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting6
Enrolling by invitation4
Recruiting3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioMarin Pharmaceutical10
QED Therapeutics, a BridgeBio company8
Alexion Pharmaceuticals, Inc.3
Amgen3
Mesoblast, Ltd.1
Pfizer1
Texas Scottish Rite Hospital for Children1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bone Diseases27
Musculoskeletal Diseases20
Dwarfism17
Achondroplasia14
Osteochondrodysplasias14
Genetic Diseases, Inborn13
Mucopolysaccharidosis IV9
Bone Diseases, Developmental7
Hypophosphatasia3
Osteomalacia3

Trials

Showing 26 to 27 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.